60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · IEX Real-Time Price · USD
0.270
-0.011 (-4.05%)
At close: Jun 14, 2024, 3:50 PM
0.283
+0.013 (4.70%)
After-hours: Jun 14, 2024, 7:45 PM EDT

SXTP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Revenue
0.250.515.51.85
Revenue Growth (YoY)
-50.40%-90.71%197.98%-
Cost of Revenue
0.470.435.190.37
Gross Profit
-0.220.080.311.48
Selling, General & Admin
4.241.31.121.46
Research & Development
0.690.535.510.81
Operating Expenses
4.931.836.632.26
Operating Income
-5.15-1.75-6.32-0.79
Interest Expense / Income
2.293.993.172.63
Other Expense / Income
-3.680.44-5.24-0.38
Pretax Income
-3.77-6.18-4.25-3.03
Income Tax
0000
Net Income
-3.77-6.18-4.25-3.03
Preferred Dividends
0.22000
Net Income Common
-3.92-6.18-4.25-3.03
Shares Outstanding (Basic)
422-
Shares Outstanding (Diluted)
42--
Shares Change
67.26%-0.77%--
EPS (Basic)
-0.99-2.61--
EPS (Diluted)
-0.99-2.61--
Free Cash Flow
-4.64-1.04-0.68-0.24
Free Cash Flow Per Share
-1.17-0.44-0.29-
Gross Margin
-87.15%15.42%5.63%80.06%
Operating Margin
-2032.78%-342.41%-114.80%-42.58%
Profit Margin
-1547.71%-1209.65%-77.27%-164.30%
Free Cash Flow Margin
-1830.05%-204.03%-12.44%-12.90%
EBITDA
-1.38-2.11-1.01-0.38
EBITDA Margin
-543.61%-413.35%-18.29%-20.34%
Depreciation & Amortization
0.10.080.070.03
EBIT
-1.48-2.19-1.08-0.4
EBIT Margin
-583.19%-428.76%-19.59%-21.85%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).